|
1
|
Ivanov S, Dragoi AM, Wang X, et al: A
novel role for HMGB1 in TLR9-mediated inflammatory responses to
CpG-DNA. Blood. 110:1970–1981. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sanjuan MA, Rao N, Lai KT, et al:
CpG-induced tyrosine phosphorylation occurs via a TLR9-independent
mechanism and is required for cytokine secretion. J Cell Biol.
172:1057–1068. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takeshita F, Gursel I, Ishii KJ, Suzuki K,
Gursel M and Klinman DM: Signal transduction pathways mediated by
the interaction of CpG DNA with Toll-like receptor 9. Semin
Immunol. 16:17–22. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawai T, Sato S, Ishii KJ, et al:
Interferon-alpha induction through Toll-like receptors involves a
direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol.
5:1061–1068. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bagchi A, Herrup EA, Warren HS, et al:
MyD88-dependent and MyD88-independent pathways in synergy, priming,
and tolerance between TLR agonists. J Immunol. 178:1164–1171. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bulek K, Swaidani S, Qin J, et al: The
essential role of single Ig IL-1 receptor-related molecule/Toll
IL-1R8 in regulation of Th2 immune response. J Immunol.
182:2601–2609. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee SS, Kennedy S, Tolonen AC and Ruvkun
G: DAF-16 target genes that control C. elegans life-span and
metabolism. Science. 300:644–647. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paik JH, Kollipara R, Chu G, et al: FoxOs
are lineage-restricted redundant tumor suppressors and regulate
endothelial cell homeostasis. Cell. 128:309–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, Wang Y and Zhu WG: Applications of
post-translational modifications of FoxO family proteins in
biological functions. J Mol Cell Biol. 3:276–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barthelemy C, Henderson CE and Pettmann B:
Foxo3a induces motoneuron death through the Fas pathway in
cooperation with JNK. BMC Neurosci. 5:482004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cui M, Huang Y, Zhao Y and Zheng J:
Transcription factor FOXO3a mediates apoptosis in HIV-1-infected
macrophages. J Immunol. 180:898–906. 2008. View Article : Google Scholar
|
|
12
|
Modur V, Nagarajan R, Evers BM and
Milbrandt J: FOXO proteins regulate tumor necrosis factor-related
apoptosis inducing ligand expression. Implications for PTEN
mutation in prostate cancer. J Biol Chem. 277:47928–47937. 2002.
View Article : Google Scholar
|
|
13
|
Sakoe Y, Sakoe K, Kirito K, Ozawa K and
Komatsu N: FOXO3A as a key molecule for all-trans retinoic
acid-induced granulocytic differentiation and apoptosis in acute
promyelocytic leukemia. Blood. 115:3787–3795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guan H, Song L, Cai J, et al: Sphingosine
kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to
apoptosis resistance in glioma cells. PLoS One. 6:e199462011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lim EJ, Park DW, Lee JG, et al: Toll-like
receptor 9-mediated inhibition of apoptosis occurs through
suppression of FoxO3a activity and induction of FLIP expression.
Exp Mol Med. 42:712–720. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takeda K and Akira S: Toll-like receptors
in innate immunity. Int Immunol. 17:1–14. 2005. View Article : Google Scholar
|
|
17
|
Kuo CC, Liang SM and Liang CM: CpG-B
oligodeoxynucleotide promotes cell survival via up-regulation of
Hsp70 to increase Bcl-xL and to decrease apoptosis-inducing factor
translocation. J Biol Chem. 281:38200–38207. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuo CC, Liang CM, Lai CY and Liang SM:
Involvement of heat shock protein (Hsp)90 beta but not Hsp90 alpha
in antiapoptotic effect of CpG-B oligodeoxynucleotide. J Immunol.
178:6100–6108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang S and El-Deiry WS: TRAIL and
apoptosis induction by TNF-family death receptors. Oncogene.
22:8628–8633. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mitsiades N, Mitsiades CS, Poulaki V,
Anderson KC and Treon SP: Intracellular regulation of tumor
necrosis factor-related apoptosis-inducing ligand-induced apoptosis
in human multiple myeloma cells. Blood. 99:2162–2171. 2002.
View Article : Google Scholar
|
|
21
|
Xiao CW, Asselin E and Tsang BK: Nuclear
factor kappaB-mediated induction of Flice-like inhibitory protein
prevents tumor necrosis factor alpha-induced apoptosis in rat
granulosa cells. Biol Reprod. 67:436–441. 2002. View Article : Google Scholar
|
|
22
|
Kerbauy DM, Lesnikov V, Abbasi N, Seal S,
Scott B and Deeg HJ: NF-kappaB and FLIP in arsenic trioxide
(ATO)-induced apoptosis in myelodysplastic syndromes (MDSs). Blood.
106:3917–3925. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Loeuillet C, Martinon F, Perez C, Munoz M,
Thome M and Meylan PR: Mycobacterium tuberculosis subverts
innate immunity to evade specific effectors. J Immunol.
177:6245–6255. 2006. View Article : Google Scholar
|
|
24
|
Fu Z and Tindall DJ: FOXOs, cancer and
regulation of apoptosis. Oncogene. 27:2312–2319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Greer EL and Brunet A: FOXO transcription
factors at the interface between longevity and tumor suppression.
Oncogene. 24:7410–7425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Khatri S, Yepiskoposyan H, Gallo CA,
Tandon P and Plas DR: FOXO3a regulates glycolysis via
transcriptional control of tumor suppressor TSC1. J Biol Chem.
285:15960–15965. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dragoi AM, Fu X, Ivanov S, et al:
DNA-PKcs, but not TLR9, is required for activation of Akt by
CpG-DNA. EMBO J. 24:779–789. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Francois S, El Benna J, Dang PM, Pedruzzi
E, Gougerot-Pocidalo MA and Elbim C: Inhibition of neutrophil
apoptosis by TLR agonists in whole blood: involvement of the
phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways,
leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J
Immunol. 174:3633–3642. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Krieg AM: CpG motifs in bacterial DNA and
their immune effects. Annu Rev Immunol. 20:709–760. 2002.
View Article : Google Scholar : PubMed/NCBI
|
